StockData
GH Research PLC logo

GH Research PLC (GHRS) stock

GHRSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$18.27−0.48 (-2.56%)

Close on Nov 17, 2026Market cap $1.13BP/E –Yield –

GH Research total assets

Total assets on the balance sheet at the end of each period.

GH Research's total assets was $372.35M at Jun 30, 2026. For fiscal 2025 it was $288.23M, up 53.1% from the year before. The highest annual figure on record is $288.23M in fiscal 2025.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$288.23M+53.1%
FY2024Dec 31, 2024$188.27M-16.8%
FY2023Dec 31, 2023$226.30M-11.0%
FY2022Dec 31, 2022$254.36M-9.1%
FY2021Dec 31, 2021$279.92M+4634.8%
FY2020Dec 31, 2020$5.91M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$372.35M+18.8%
Q1 FY2026Mar 31, 2026$275.27M-14.1%
Q4 FY2025Dec 31, 2025$288.23M+53.1%
Q3 FY2025Sep 30, 2025$302.02M+51.3%
Q2 FY2025Jun 30, 2025$313.43M+51.4%
Q1 FY2025Mar 31, 2025$320.45M+47.3%
Q4 FY2024Dec 31, 2024$188.27M-16.8%
Q3 FY2024Sep 30, 2024$199.61M-14.2%
Q2 FY2024Jun 30, 2024$206.98M-13.9%
Q1 FY2024Mar 31, 2024$217.58M-14.5%
Q4 FY2023Dec 31, 2023$226.30M-19.2%
Q3 FY2023Sep 30, 2023$232.57M+3833.8%
Q2 FY2023Jun 30, 2023$240.27M–
Q4 FY2022Dec 31, 2022$254.36M–
Q4 FY2021Dec 31, 2021$279.92M–
Q4 FY2020Dec 31, 2020$5.91M–

More GH Research figures

See a number that looks wrong?